2,3-dihydro-4(1H)- quinazolone derivative and application thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- SHANGAI PHARMA GRP CO LTD
- Publication Date
- 2011-01-05
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The present invention specifically relates to a 2,3-dihydro-4(1H)-quinazolone derivative, its pharmaceutically acceptable salt or solvate, and its pharmaceutical composition and application. Background technique
[0002] Angiogenesis is the process of generating new blood vessels from pre-existing vascular beds. Under normal circumstances, angiogenesis is strictly controlled in some transient, specific physiological processes, such as: reproductive process, developmental process and wound healing process. Sustained angiogenesis is the performance of certain diseases, such as: malignant growth of tumor tissue, diabetic retinopathy and so on.
[0003] Studies have shown that tumor is an angiogenesis-dependent disease, and the growth, invasion and metastasis of primary tumors all require the generation of new blood vessels. Neovascularization provides sufficient oxygen and nutrients for tumor cells, and its endothelial cells express a variety of growth ...